We hold ourselves accountable to only 3 questions:

1) Yesterday, did the patients, customers, team, investors, and stakeholders win?

2) Today, are clinical trials succeeding more often so that humanity can make better medicine faster?

3) Tomorrow, if the next global pandemic arrived, are we ready to help the world find the cure, better, faster, and cheaper?

The global burden of disease will hit $47 Trillion by 2035. Yet only 8% of clinical trials currently deliver a new treatment to patients.

Increasing this trial success rate will transform outcomes for patients and families and bring better medicine to over 1 billion people worldwide, especially seniors.

Turning clinical trials into a self improving engine for medicine, where new trials learn from prior trials will unlock > $10 Trillion in pharma value.

This is where the next trillion dollar pharma company will be built.

Read more on www.clinicaltrials.bio

We work in a team that prioritizes health, community, and social good.

We work hard. We take responsibility. We lead.

Artificial Medical Intelligence (AME) is the use of AI systems to accelerate the discovery, development, and delivery of better healthcare.

Clinical Trial Intelligence (CTI) is a system that brings humans wisdom to see which trials to fund and how to design them for success.

Autonomous Pharma (AP) is a model where AI agents run core drug-development functions to discover, evaluate, and advance new medicines

Full Stack AI (FSA) Company is one where most core functions are run by specialized AI agents.